🎧 Select dubbed video language:

0:00 / 0:00

Cardiac Surgery

Dr. Pier Mannuccio Mannucci

1. Dr. Pier Mannuccio Mannucci. Experte für Hämatologie. Biografie. 0

Dr. Pier Mannucci, MD, explains advances in hemophilia and von Willebrand disease treatment. He discusses the genetic links between blood clots and undiagnosed cancer.

2. VITT. impfstoffinduzierte thrombotische Thrombozytopenie und COVID-19-Impfung. 11. [Teile 1 und 2]

Dr. Pier Mannucci, MD, explains the rare but serious condition of vaccine-induced thrombotic thrombocytopenia (VITT). He details the unique pathophysiology of VITT, which causes both...

3. Chronische Lebererkrankung. Wie wendet man Labortests richtig an? 1

Dr. Pier Mannucci, MD, explains how to correctly interpret coagulation tests. He clarifies that abnormal prothrombin time does not predict bleeding risk in liver patients....

4. Risiko von Blutgerinnseln und Mutationen. Gentest machen oder nicht? 4. [Teile 1 und 2]

Dr. Pier Mannucci, MD, explains the limited clinical utility of genetic testing for blood clot risk mutations. He details how common mutations like Factor V...

5. Personalisierte Ernährung. Wie man richtiges Essen gut auswählt? 8. [Teile 1 und 2]

Dr. Pier Mannucci, MD, explains how personalized nutrition tailors diet to individual health risks. He emphasizes that food processing is more critical than macronutrient composition....

6. Luftverschmutzung und Herzerkrankungen. Wie können Sie Ihre Risiken senken? 9. [Teile 1 und 2]

Dr. Anton Titov, MD, explores practical strategies for individuals to lower their personal exposure risks in urban environments.

7. Polypharmazie bei älteren Patienten. Warum verschreiben Ärzte zu viele Medikamente? 10. [Teile 1 und 2]

Dr. Pier Mannucci, MD, explains why elderly patients are prescribed too many medications. He details the severe risks of polypharmacy, including adverse drug events and...

8. Von-Willebrand-Krankheit. Neue Behandlungsmöglichkeiten. MGUS. Erworbener VWD. 2

Dr. Pier Mannuccio Mannucci, MD, covers the importance of specialist referral for accurate diagnosis. Von Willebrand disease is the most common inherited bleeding disorder.

9. Hämophilie. Neue Behandlungsmöglichkeiten. Emicizumab. Gentherapie. 3 [Teil 1 und 2]

Dr. Anton Titov, MD, facilitates this in-depth discussion on precision medicine for hemophilia.

10. Tiefe Venenthrombose und Krebsrisiko. Heparin und Aspirin bei TVT. 5

Dr. Pier Mannucci, MD, explains the complex relationship between cancer and blood clots. He details the use of low molecular weight heparin and direct oral...

11. Direkte orale Antikoagulanzien oder Vitamin-K-Antagonisten? Wann verwenden? 6

Dr. Pier Mannucci, MD, explains the advantages of direct oral anticoagulants over older vitamin K antagonists. He details the superior convenience and safety profile of...

12. Vorhofflimmern bei älteren Patienten. Thrombose vs. Blutungsrisiko. 7

Dr. Pier Mannucci, MD, explains the critical balance between stroke prevention and bleeding risk in elderly atrial fibrillation patients. He emphasizes that stroke risk significantly...

13. MGUS und erworbenes von-Willebrand-Syndrom. 12

Dr. Anton Titov, MD, explores the rare but serious complication of bleeding from acquired von Willebrand disease.

Verfeinern Sie Ihren Behandlungsplan bis zur Perfektion durch ein Gremium von 3 bis 10+ Top-Ärzten, die perfekt für Sie sind.

Can we help?